US 12264187
Compositions and methods for targeted therapeutic delivery to bone
granted A61KA61K38/00A61K38/18
Quick answer
US patent 12264187 (Compositions and methods for targeted therapeutic delivery to bone) held by Theradaptive, Inc. expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theradaptive, Inc.
- Grant date
- Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K38/00, A61K38/18, A61P, A61P19/00